Magnolia Capital Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.19M Buy
34,804
+30,263
+666% +$3.49M 0.82% 36
2025
Q4
$478K Sell
4,541
-468
-9% -$43.9K 0.1% 181
2025
Q3
$420K Sell
5,009
-583
-10% -$48K 0.11% 161
2025
Q2
$443K Sell
5,592
-13,723
-71% -$1.09M 0.11% 166
2025
Q1
$1.73M Buy
19,315
+962
+5% +$89.8K 0.47% 52
2024
Q4
$1.83M Buy
18,353
+6,138
+50% +$633K 0.47% 50
2024
Q3
$1.39M Buy
12,215
+282
+2% +$33.5K 0.69% 36
2024
Q2
$1.48M Sell
11,933
-5,707
-32% -$735K 0.83% 36
2024
Q1
$2.22M Buy
17,640
+1,685
+11% +$208K 1.86% 15
2023
Q4
$1.94M Buy
15,955
+857
+6% +$89K 1.42% 18
2023
Q3
$1.55M Sell
15,098
-74
-0.5% -$7.98K 1.49% 13
2023
Q2
$1.75M Sell
15,172
-2,310
-13% -$262K 0.88% 35
2023
Q1
$1.86M Sell
17,482
-141
-0.8% -$15.2K 0.96% 29
2022
Q4
$1.96M Sell
17,623
-193
-1% -$19.7K 1.3% 17
2022
Q3
$1.53M Sell
17,816
-111
-0.6% -$9.91K 1.3% 18
2022
Q2
$1.63M Sell
17,927
-2,235
-11% -$198K 1.49% 18
2022
Q1
$1.65M Sell
20,162
-770
-4% -$60.7K 0.65% 43
2021
Q4
$1.6M Buy
20,932
+2,502
+14% +$199K 0.47% 50
2021
Q3
$1.38M Buy
18,430
+2,179
+13% +$166K 0.48% 52
2021
Q2
$1.26M Buy
+16,251
New +$1.21M 0.56% 46
2021
Q1
Sell
-6,645
Closed -$519K 108
2020
Q4
$519K Buy
6,645
+459
+7% +$35.1K 0.34% 48
2020
Q3
$490K Buy
6,186
+153
+3% +$12K 0.39% 42
2020
Q2
$445K Sell
6,033
-630
-9% -$47.4K 0.57% 33
2020
Q1
$489K Sell
6,663
-149
-2% -$11.7K 0.95% 26
2019
Q4
$591K Buy
+6,812
New +$560K 0.56% 32

Other funds holding MRK

Magnolia Capital Advisors's MRK Position: Q1 2026 in Review

Magnolia Capital Advisors increased its Merck (MRK) stake by 666% in Q1 2026, buying an estimated $3.49M and bringing the position to 34,804 shares worth $4.19M. The position accounts for 0.82% of the portfolio, ranked #36.

Magnolia Capital Advisors first reported a position in MRK in Q4 2019 and has held it in 25 quarters since. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Magnolia Capital Advisors held 34,804 shares of Merck worth $4.19M as of Q1 2026.
  • Magnolia Capital Advisors bought 30,263 Merck shares in Q1 2026, an estimated $3.49M.
  • Merck made up 0.82% of Magnolia Capital Advisors's portfolio in Q1 2026, its #36 holding.
  • Magnolia Capital Advisors first reported a position in Merck in Q4 2019 and has held it in 25 quarters since.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Magnolia Capital Advisors's 13F filing for Q1 2026, filed 15 May 2026.